These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 25829804
1. A phase 2 multi-center, open-label, switch-over trial to evaluate the safety and efficacy of Abcertin® in patients with type 1 Gaucher disease. Choi JH, Lee BH, Ko JM, Sohn YB, Lee JS, Kim GH, Heo SH, Park JY, Kim YM, Kim JH, Yoo HW. J Korean Med Sci; 2015 Apr; 30(4):378-84. PubMed ID: 25829804 [Abstract] [Full Text] [Related]
2. Velaglucerase alfa for the management of type 1 Gaucher disease. Morris JL. Clin Ther; 2012 Feb; 34(2):259-71. PubMed ID: 22264444 [Abstract] [Full Text] [Related]
3. A multicenter, open-label, phase III study of Abcertin in Gaucher disease. Lee BH, Abdalla AF, Choi JH, Beshlawy AE, Kim GH, Heo SH, Megahed AMH, Elsayed MAL, Barakat TEM, Eid KMAE, El-Tagui MH, Mahmoud MMH, Fateen E, Park JY, Yoo HW. Medicine (Baltimore); 2017 Nov; 96(45):e8492. PubMed ID: 29137040 [Abstract] [Full Text] [Related]
4. A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase. Pastores GM, Petakov M, Giraldo P, Rosenbaum H, Szer J, Deegan PB, Amato DJ, Mengel E, Tan ES, Chertkoff R, Brill-Almon E, Zimran A. Blood Cells Mol Dis; 2014 Dec; 53(4):253-60. PubMed ID: 24950666 [Abstract] [Full Text] [Related]
6. Enzyme replacement and substrate reduction therapy for Gaucher disease. Shemesh E, Deroma L, Bembi B, Deegan P, Hollak C, Weinreb NJ, Cox TM. Cochrane Database Syst Rev; 2015 Mar 27; 2015(3):CD010324. PubMed ID: 25812601 [Abstract] [Full Text] [Related]
7. Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease. Elstein D, Mehta A, Hughes DA, Giraldo P, Charrow J, Smith L, Shankar SP, Hangartner TN, Kunes Y, Wang N, Crombez E, Zimran A. Am J Hematol; 2015 Jul 27; 90(7):592-7. PubMed ID: 25776130 [Abstract] [Full Text] [Related]
10. Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment. Weinreb NJ, Camelo JS, Charrow J, McClain MR, Mistry P, Belmatoug N, International Collaborative Gaucher Group (ICGG) Gaucher Registry (NCT00358943) investigators. Mol Genet Metab; 2021 Feb 27; 132(2):100-111. PubMed ID: 33485799 [Abstract] [Full Text] [Related]
11. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease. Wenstrup RJ, Kacena KA, Kaplan P, Pastores GM, Prakash-Cheng A, Zimran A, Hangartner TN. J Bone Miner Res; 2007 Jan 27; 22(1):119-26. PubMed ID: 17032149 [Abstract] [Full Text] [Related]
12. Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease. Ben Turkia H, Gonzalez DE, Barton NW, Zimran A, Kabra M, Lukina EA, Giraldo P, Kisinovsky I, Bavdekar A, Ben Dridi MF, Gupta N, Kishnani PS, Sureshkumar EK, Wang N, Crombez E, Bhirangi K, Mehta A. Am J Hematol; 2013 Mar 27; 88(3):179-84. PubMed ID: 23400823 [Abstract] [Full Text] [Related]
13. Recombinant macrophage targeted enzyme replacement therapy for Gaucher disease in India. Nagral A, Mewawalla P, Jagadeesh S, Kabra M, Phadke SR, Verma IC, Puri RD, Gupta N, Kishnani PS, Mistry PK. Indian Pediatr; 2011 Oct 27; 48(10):779-84. PubMed ID: 22080680 [Abstract] [Full Text] [Related]
14. Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report. Giuffrida G, Lombardo R, Di Francesco E, Parrinello L, Di Raimondo F, Fiumara A. J Med Case Rep; 2016 Nov 08; 10(1):315. PubMed ID: 27821156 [Abstract] [Full Text] [Related]
15. Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase. Smith L, Rhead W, Charrow J, Shankar SP, Bavdekar A, Longo N, Mardach R, Harmatz P, Hangartner T, Lee HM, Crombez E, Pastores GM. Mol Genet Metab; 2016 Feb 08; 117(2):164-71. PubMed ID: 26043810 [Abstract] [Full Text] [Related]
16. Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: early Access Program results from Jerusalem. Elstein D, Altarescu G, Maayan H, Phillips M, Abrahamov A, Hadas-Halpern I, Tiomkin M, Zimran A. Blood Cells Mol Dis; 2012 Jan 15; 48(1):45-50. PubMed ID: 22047948 [Abstract] [Full Text] [Related]
17. Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy. Cox TM, Drelichman G, Cravo R, Balwani M, Burrow TA, Martins AM, Lukina E, Rosenbloom B, Goker-Alpan O, Watman N, El-Beshlawy A, Kishnani PS, Pedroso ML, Gaemers SJM, Tayag R, Peterschmitt MJ. Blood; 2017 Apr 27; 129(17):2375-2383. PubMed ID: 28167660 [Abstract] [Full Text] [Related]
18. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. El-Beshlawy A, Tylki-Szymanska A, Vellodi A, Belmatoug N, Grabowski GA, Kolodny EH, Batista JL, Cox GF, Mistry PK. Mol Genet Metab; 2017 Apr 27; 120(1-2):47-56. PubMed ID: 28040394 [Abstract] [Full Text] [Related]
19. Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase. Zimran A, Pastores GM, Tylki-Szymanska A, Hughes DA, Elstein D, Mardach R, Eng C, Smith L, Heisel-Kurth M, Charrow J, Harmatz P, Fernhoff P, Rhead W, Longo N, Giraldo P, Ruiz JA, Zahrieh D, Crombez E, Grabowski GA. Am J Hematol; 2013 Mar 27; 88(3):172-8. PubMed ID: 23339116 [Abstract] [Full Text] [Related]
20. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study. Heitner R, Arndt S, Levin JB. S Afr Med J; 2004 Aug 27; 94(8):647-51. PubMed ID: 15352589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]